| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,195 |
1,758 |
$105K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,132 |
1,007 |
$88K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
490 |
260 |
$38K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
413 |
361 |
$30K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
188 |
157 |
$15K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
178 |
126 |
$13K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
91 |
87 |
$13K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
287 |
261 |
$12K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
629 |
546 |
$12K |
| 96127 |
|
358 |
309 |
$5K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
106 |
88 |
$5K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
66 |
63 |
$5K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
143 |
135 |
$4K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
13 |
12 |
$903.76 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
18 |
18 |
$563.40 |
| 80061 |
Lipid panel |
42 |
28 |
$313.73 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
18 |
15 |
$282.60 |
| 36416 |
|
56 |
41 |
$205.00 |
| 85018 |
|
49 |
41 |
$113.68 |
| 81003 |
|
28 |
26 |
$58.86 |
| 91300 |
|
15 |
15 |
$0.15 |
| 1036F |
|
86 |
59 |
$0.00 |
| 1220F |
|
86 |
59 |
$0.00 |
| 1003F |
|
403 |
295 |
$0.00 |
| 99072 |
|
200 |
147 |
$0.00 |